Titlebook: Ovarian Cancer; David S. Alberts,Earl A. Surwit Book 1985 Martinus Nijhoff Publishers, Boston 1985 Staging.cancer treatment.carcinoma.cell

CHAFF

書目名稱Ovarian Cancer影響因子(影響力)




書目名稱Ovarian Cancer影響因子(影響力)學(xué)科排名




書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度




書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Ovarian Cancer被引頻次




書目名稱Ovarian Cancer被引頻次學(xué)科排名




書目名稱Ovarian Cancer年度引用




書目名稱Ovarian Cancer年度引用學(xué)科排名




書目名稱Ovarian Cancer讀者反饋




書目名稱Ovarian Cancer讀者反饋學(xué)科排名

ABYSS

同謀

The human tumor clonogenic assay used to study ovarian cancers,47 showed that the addition of cisplatin to cyclophosphamide and doxorubicin improved response rates from 46% to 71% with the median duration of survival increasing from 9.5 months to 15.0 months [3]. The fact, however, becomes apparent that a. survival duration of 15 months is not a cure, and the g

neutrophils

郊外

征兵

0927-3042 fashion. First, by di- viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by978-1-4612-9609-6978-1-4613-2561-1Series ISSN 0927-3042 Series E-ISSN 2509-8497

Musket

Book 1985extbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre- quently publish good in-depth reviews of cancer topics, and published sym-

擴(kuò)張

不法行為

Fracture

Multiagent chemotherapy in advanced ovarian carcinoma,e taken place. In fact, dealing with this tumor remains a frustrating experience to all cancer specialists. Advanced ovarian carcinoma (FIGO Stages III and IV) remains the most common gynecologic cancer killer with 18,200 estimated new cases and 11,500 estimated deaths in 1983 (6% of all female cancer deaths) [1].